Search Results
509 results
Your search is now limited to «Partnerships and Collaborations» expert search.
Under its two licensing and collaboration agreements with Lilly, Zymeworks has granted Lilly worldwide licenses to research, develop, and commercialize multiple bispecific therapeutics directed towards Lilly’s targets.
More from Pharmaceutical Business Review:
MedCity News 01/18/2019 14:12
Bristol-Myers Squibb agreed to acquire Celgene for $74 billion earlier this month.
More from MedCity News:
NASDAQ 01/18/2019 11:53
The study's goals include measuring the outcomes of a heart health engagement program with irregular rhythm notifications on Apple Watch, and assessing the impact of a medication adherence program using an app from Johnson & Johnson.
More from NASDAQ:
PharmaManufacturing 01/18/2019 10:28
Celgene's $80 million upfront payment will give the drugmaker exclusive options to two Kyn therapeutic programs — an aryl hydrocarbon receptor (AHR) antagonist program and its kynurenine-degrading enzyme (“Kynase”) program.
More from PharmaManufacturing:
On its way to acquisition by Bristol-Myers Squibb (BMS), Celgene continues to pursue its own cancer-focused collaborations, with a pair of biotechs announcing the partnerships today.
More from Genetic Engineering & Biotechnology News:
WN.com 01/18/2019 09:26
Obsidian Therapeutics Announces Strategic Collaboration with Celgene to Develop Novel Cell Therapies with Tunable Immunomodulatory Factors,... Obsidian Therapeutics ......
More from WN.com:
ENDPOINTS 01/18/2019 07:15
The collaboration signals Celgene’s “continued commitment to work with partners,” said Robert Hershberg, head of business development and global alliances.
More from ENDPOINTS:
Business Wire 01/18/2019 07:00
The collaboration includes an upfront payment and equity investment by Celgene, and potential future milestone and royalty payments.
More from Business Wire:
MobiHealthNews 01/17/2019 14:34
Earlier today, Johnson & Johnson announced plans for a multi-year research program it will be launching with Apple to explore the role Apple Watches could play in senior health monitoring.
More from MobiHealthNews:
MarketWatch 01/17/2019 08:43
The study will investigate whether a heart health app by Johnson & Johnson, combined with Apple Watch's irregular rhythm notifications and ECG app, can accelerate diagnosis and improve outcomes for people with atrial fibrillation.
More from MarketWatch:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications